These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1746507)

  • 21. Buprenorphrine: demonstration of physical dependence liability.
    Dum J; Bläsig J; Herz A
    Eur J Pharmacol; 1981 Mar; 70(3):293-300. PubMed ID: 6262095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effectiveness of different singly administered high doses of buprenorphine in reducing suicidal ideation in acutely depressed people with co-morbid opiate dependence: a randomized, double-blind, clinical trial.
    Ahmadi J; Jahromi MS; Ehsaei Z
    Trials; 2018 Aug; 19(1):462. PubMed ID: 30157924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Postoperative analgesia after cesarean section: sublingual buprenorphine versus subcutaneous morphine].
    Abid A; Benhamou D; Labaille T
    Ann Fr Anesth Reanim; 1990; 9(3):275-9. PubMed ID: 2372154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of buprenorphine/naloxone in opioid-dependent humans.
    Stoller KB; Bigelow GE; Walsh SL; Strain EC
    Psychopharmacology (Berl); 2001 Mar; 154(3):230-42. PubMed ID: 11351930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine.
    Daitch J; Frey ME; Silver D; Mitnick C; Daitch D; Pergolizzi J
    Pain Physician; 2012 Jul; 15(3 Suppl):ES59-66. PubMed ID: 22786462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers.
    Comer SD; Sullivan MA; Whittington RA; Vosburg SK; Kowalczyk WJ
    Neuropsychopharmacology; 2008 Apr; 33(5):1179-91. PubMed ID: 17581533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Buprenorphine, morphine and naloxone effects during ascending morphine maintenance in humans.
    Schuh KJ; Walsh SL; Bigelow GE; Preston KL; Stitzer ML
    J Pharmacol Exp Ther; 1996 Aug; 278(2):836-46. PubMed ID: 8768738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts.
    Fudala PJ; Yu E; Macfadden W; Boardman C; Chiang CN
    Drug Alcohol Depend; 1998 Mar; 50(1):1-8. PubMed ID: 9589267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients.
    Nosek K; Leppert W; Nosek H; Wordliczek J; Onichimowski D
    Drug Des Devel Ther; 2017; 11():2409-2419. PubMed ID: 28860712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment and management of opioid withdrawal symptoms in buprenorphine-dependent subjects.
    San L; Camí J; Fernández T; Ollé JM; Peri JM; Torrens M
    Br J Addict; 1992 Jan; 87(1):55-62. PubMed ID: 1311974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Buprenorphine effects on morphine- and cocaine-induced subjective responses by drug-dependent men.
    Teoh SK; Mello NK; Mendelson JH; Kuehnle J; Gastfriend DR; Rhoades E; Sholar W
    J Clin Psychopharmacol; 1994 Feb; 14(1):15-27. PubMed ID: 8151000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
    Kögel B; Christoph T; Strassburger W; Friderichs E
    Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers.
    Strain EC; Stoller K; Walsh SL; Bigelow GE
    Psychopharmacology (Berl); 2000 Mar; 148(4):374-83. PubMed ID: 10928310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid effects and opioid withdrawal during a 24 h dosing interval in patients maintained on buprenorphine.
    Lopatko OV; White JM; Huber A; Ling W
    Drug Alcohol Depend; 2003 Apr; 69(3):317-22. PubMed ID: 12633918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inpatient initiation of buprenorphine maintenance vs. detoxification: can retention of opioid-dependent patients in outpatient counseling be improved?
    Caldiero RM; Parran TV; Adelman CL; Piche B
    Am J Addict; 2006; 15(1):1-7. PubMed ID: 16449087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection.
    Umbricht A; Hoover DR; Tucker MJ; Leslie JM; Chaisson RE; Preston KL
    Drug Alcohol Depend; 2003 Apr; 69(3):263-72. PubMed ID: 12633912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of heroin addicts using buprenorphine.
    Kosten TR; Morgan C; Kleber HD
    Am J Drug Alcohol Abuse; 1991 Jun; 17(2):119-28. PubMed ID: 1862786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transdermal buprenorphine, opioid rotation to sublingual buprenorphine, and the avoidance of precipitated withdrawal: a review of the literature and demonstration in three chronic pain patients treated with butrans.
    Kornfeld H; Reetz H
    Am J Ther; 2015; 22(3):199-205. PubMed ID: 23846520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sublingual buprenorphine compared to morphine delivered by a patient-controlled analgesia system as postoperative analgesia after prostatectomy.
    Gaitini L; Moskovitz B; Katz E; Vaisberg A; Vaida S; Nativ O
    Urol Int; 1996; 57(4):227-9. PubMed ID: 8961492
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.